OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multifaceted roles of IL-38 in inflammation and cancer
Alejandro Díaz-Barreiro, Arnaud Huard, Gaby Palmer
Cytokine (2022) Vol. 151, pp. 155808-155808
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Interleukin-38 and Insulin Resistance
Kamil Klejbuk, Marek Strączkowski
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 24, Iss. 6, pp. 611-616
Closed Access | Times Cited: 21

Identifying biomarkers deciphering sepsis from trauma-induced sterile inflammation and trauma-induced sepsis
Praveen Papareddy, Michael Selle, Nicolas Partouche, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6

The Role of Genetics and Epigenetic Regulation in the Pathogenesis of Osteoarthritis
Kajetan Kiełbowski, Mariola Herian, Estera Bakinowska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11655-11655
Open Access | Times Cited: 14

Exploring the clinical significance of IL-38 correlation with PD-1, CTLA-4, and FOXP3 in colorectal cancer draining lymph nodes
Liuhong Yuan, Zhenyu Tan, Junjie Huang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

IL-38 promotes the development of prostate cancer
Huiyan Wu, Jing Yang, Liuhong Yuan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

Full-length and N-terminally truncated recombinant interleukin-38 variants are similarly inefficient in antagonizing interleukin-36 and interleukin-1 receptors
Alejandro Díaz-Barreiro, Dominique Talabot‐Ayer, Arnaud Huard, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access

Interleukin-38 as a potential diagnostic biomarker for heart failure
Hongman Liu, Mingliang Zhang, Wen Gong, et al.
Biomarkers in Medicine (2025), pp. 1-7
Closed Access

The distinct roles of IL-37 and IL-38 in non-small cell lung carcinoma and their clinical implications
Jiwei Zhang, Steven G. Wise, Shunqing Zuo, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

IL-1RAP, a Key Therapeutic Target in Cancer
Jame Frenay, Pierre‐Simon Bellaye, Alexandra Oudot, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14918-14918
Open Access | Times Cited: 15

IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation
John P. Dowling, Pavel A. Nikitin, Fang Shen, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8

Emerging functions and therapeutic targets of IL‐38 in central nervous system diseases
Yuan Gao, Luwei Cai, Yulu Wu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 2

Harnessing confounding and genetic pleiotropy to identify causes of disease through proteomics and Mendelian randomisation - 'MR Fish'.
Alasdair Warwick, Aroon D. Hingorani, Anthony P. Khawaja, et al.
(2024)
Closed Access | Times Cited: 2

Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice
Arnaud Huard, Emiliana Rodriguez, Dominique Talabot‐Ayer, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Neutralizing IL-38 activates γδ T cell-dependent antitumor immunity and sensitizes for chemotherapy
Priscila da Silva, Javier Mora, Xin You, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 8, pp. e008641-e008641
Open Access | Times Cited: 2

IL-36 expression is increased in NSCLC with IL-36 stimulation of lung cancer cells promoting a pro-tumorigenic phenotype
Kevin James Baker, Emily Buskiewicz, Méabh Finucane, et al.
Cytokine (2023) Vol. 165, pp. 156170-156170
Open Access | Times Cited: 6

Cell Intrinsic IL-38 Affects B Cell Differentiation and Antibody Production
Arnaud Huard, Christian Wilmes, Anastasiia Kiprina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5676-5676
Open Access | Times Cited: 6

Aging considerations of cytokines (IL-18, IL-36α, IL-37, and IL-38) associated with rheumatoid arthritis
Nabaa S. Abdul-Sahib, Majid Mohammed Mahmood, Ali H. Ad’hiah
Egyptian Journal of Basic and Applied Sciences (2024) Vol. 11, Iss. 1, pp. 104-115
Open Access | Times Cited: 1

Circulating interleukin-38 concentrations in healthy adults
Lisa U. Teufel, Dennis M. de Graaf, Mihai G. Netea, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6

Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders
Mohammad Reza Haghshenas, Mina Roshan Zamir, Mahboubeh Sadeghi, et al.
European Cytokine Network (2022) Vol. 33, Iss. 3, pp. 54-69
Open Access | Times Cited: 5

Estimate the relationship between CXCR4-SDF-1 axis and inhibitory molecules (CTLA4 and PD-1) in patients with colon cancer
Suhad D. Abdul-Huseen, Hazima Mossa Alabassi
Narra J (2024) Vol. 4, Iss. 3, pp. e992-e992
Closed Access

Oxidation-sensitive cysteines drive IL-38 amyloid formation
Alejandro Díaz-Barreiro, Gea Cereghetti, Francisco G. Ortega, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114940-114940
Open Access

The role of IL-1 family cytokines in diabetic cardiomyopathy
Qi Wu, Yan Zeng, Kang Geng, et al.
Metabolism (2024), pp. 156083-156083
Closed Access

Advances in understanding the role of interleukins in pulmonary fibrosis (Review)
Yuqing He, Xuebin Shen, Kefeng Zhai, et al.
Experimental and Therapeutic Medicine (2024) Vol. 29, Iss. 2
Open Access

Interleukin-38-overexpressing adenovirus infection in dendritic cell-based treatment enhances immunotherapy for allergic asthma via inducing Foxp3+ regulatory T cells
Hsiao‐Chi Chuang, Jer‐Hwa Chang, Yen-Yi Fan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 181, pp. 117738-117738
Open Access

Page 1 - Next Page

Scroll to top